Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC

Part of paid clinical trials in Bessemer, Alabama.

Sponsor
Pfizer
Study ID
NCT00313768
Phase
PHASE2
Status
Terminated

Conditions

  • Carcinoma, Non-Small-Cell Lung

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

To assess the efficacy and safety of PF-3512676 administered in combination with paclitaxel, carboplatin and bevacizumab as first-line treatment in patients with locally advanced or metastatic nonsquamous non-small cell lung cancer

Key Dates

First listed
Apr 12, 2006
Start date
Dec 31, 2005
Status verified
Sep 2009
Primary completion
May 31, 2008
Completion
May 31, 2008

Study Design

Enrollment
23 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: B
    Standard of care chemotherapy
  • Experimental: A
    Standard of care chemotherapy plus experimental intervention (PF-3512676)

Primary Outcome Measure

Progression-free survival [ Time Frame: 110 Events ]

Locations (29)

FacilityCityStateZIPSite coordinators
Pfizer Investigational SiteBessemerAlabama35022-
Pfizer Investigational SiteBirminghamAlabama32511-
Pfizer Investigational SiteBirminghamAlabama35205-
Pfizer Investigational SiteBirminghamAlabama35209-
Pfizer Investigational SiteBirminghamAlabama35213-
Pfizer Investigational SiteBirminghamAlabama35235-
Pfizer Investigational SiteMobileAlabama36607-
Pfizer Investigational SiteFountain ValleyCalifornia92708-
Pfizer Investigational SiteLos AngelesCalifornia90033-
Pfizer Investigational SiteCocoa BeachFlorida32931-
Pfizer Investigational SiteMerritt IslandFlorida32952-
Pfizer Investigational SiteRockledgeFlorida32955-
Pfizer Investigational SiteTitusvilleFlorida32796-
Pfizer Investigational SiteValdostaGeorgia31602-
Pfizer Investigational SiteJolietIllinois60432-
Pfizer Investigational SiteJolietIllinois60435-
Pfizer Investigational SiteBaltimoreMaryland21231-
Pfizer Investigational SiteClintonNorth Carolina28382-
Pfizer Investigational SiteGoldsboroNorth Carolina27534-
Pfizer Investigational SitePollocksvilleNorth Carolina28573-
Pfizer Investigational SiteWilsonNorth Carolina27893-
Pfizer Investigational SiteKnoxvilleTennessee37920-
Pfizer Investigational SiteKnoxvilleTennessee37934-
Pfizer Investigational SiteAustinTexas78705-
Pfizer Investigational SiteAustinTexas78745-
Pfizer Investigational SiteAustinTexas78758-
Pfizer Investigational SiteAustinTexas78759-
Pfizer Investigational SiteGeorgetownTexas78626-
Pfizer Investigational SiteSan MarcosTexas78666-

Find similar trials in Bessemer, AL

Related Studies